Table 1: Patient demographics and disease distribution.
| Variables | Neoadjuvant Chemotherapy [16] | Primary Cytoreductive surgery [28] | P value |
| 1. Age (mean years) | 62.9 | 62.4 | 0.865 |
| 2. Ethnicity, n (%) |
| White Caucasian | 11 (68.8%) | 21 (73.0%) | 0.278 |
| Afro-Caribbean | 2 (12.5%) | 6 (21.4%) |
| Asian | 3 (18.7%) | 1 (03.6%) |
| 3. Performance status (WHO) |
| 0 | 5 (31.3%) | 14 (50.0%) | 0.223 |
| 1 | 10 (62.5%) | 13 (46.4%) |
| 2 | 0 (0%) | 01 (03.6%) |
| 3 | 1 (06.2%) | 0 (0%) |
| 4. Comorbidities |
| Obesity | 3 (18.8%) | 1 (03.6%) | 0.129 |
| Diabetes | 1 (06.2%) | 3 (10.6%) | 0.620 |
| Hypertension | 2 (12.5%) | 12 (42.9%) | 0.038 |
| Asthma/COPD | 2 (12.5%) | 4 (14.3%) | 0.868 |
| DVT/PE | 4 (25.0%) | 0 (0%) | 0.013 |
| Cardiac(Arrhythmias) | 0 (0%) | 3 (10.6%) | 0.175 |
| 5. Histology |
| Serous / Mixed Serous | 12(75.0%) | 15 (53.6%) | 0.427 |
| Clear cell | 1 (06.2%) | 4 (14.3%) |
| Endometrioid | 3 (18.8%) | 9 (32.1%) |
| 6. Stage |
| IIIC1 | 0 (0%) | 2 (07.2%) | 0.019 |
| IIIC2 | 1 (06.3%) | 9 (32.1%) |
| IVA | 0 (0%) | 0 (0%) |
| IVB | 15 (93.7%) | 17(60.7%) |